NCT01570244

Drug-drug Interaction of BI 201335 and Microgynon

An Open-label, Two-period, Fixed-sequence, Phase I Trial to Evaluate the Effect of Multiple Doses of 240 mg BI 201335 QD on the Multiple-dose Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Healthy Premenopausal Female Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 16 (actual)
• Sponsor: Boehringer Ingelheim · Industry
• Sex: Female
• Age: 18 Years – 35 Years
• Healthy volunteers: Accepted

Summary

This study will investigate possible effect of multiple oral doses of BI 201335 on the steady state pharmacokinetics of ethinylestradiol and levonogestrel

Conditions

• Hepatitis C, Chronic

Interventions

Type	Name	Description
DRUG	levonorgestrel	multiple doses
DRUG	Ethinylestradiol	multiple doses
DRUG	levonorgestrel	multiple doses
DRUG	BI 201335	multiple doses
DRUG	Ethinylestradiol	multiple doses

Timeline

• Start date: 2012-04-01
• Primary completion: 2012-08-01
• Completion: 2012-08-01
• First posted: 2012-04-04
• Last updated: 2015-08-03
• Results posted: 2015-08-03

Locations

1 site across 1 country: Germany